Clinical Trial Update: Trial of pIL-12 Electroporation Malignant Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for pIL-12 electroporation in malignant melanoma completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• pIL-12 electroporation (interleukin-12 delivered by electroporation)

Snippet

Sponsor: OncoSec Medical Incorporated | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2019-09-26